Source comparison
MOTS-C vs Traditional Cognitive Enhancement: Mechanism Comparison
MOTS-C Mitochondrial biogenesis via AMPK/PGC-1α activation Restores ATP production capacity in neurons Direct mitochondrial electron transport enhancement Low. No receptor desensitisation Phase II trials in metabolic disorders; cognitive data from controlled s
This comparison does not assign a generated winner or score.
- MOTS-C
- Mitochondrial biogenesis via AMPK/PGC-1α activation
- Restores ATP production capacity in neurons
- Direct mitochondrial electron transport enhancement
- Low. No receptor desensitisation
- Phase II trials in metabolic disorders; cognitive data from controlled studies
- Caffeine
- Adenosine receptor antagonism
- Masks fatigue signals without restoring energy
- No direct effect on ATP synthesis
- High. Tolerance develops within 7–14 days of daily use
- Extensive pharmacological data; effects are symptomatic not restorative
- Modafinil
- Dopamine reuptake inhibition + orexin activation
- Increases arousal and wakefulness
- Indirect. Increases glucose utilisation without improving efficiency
- Moderate. Some tolerance to wakefulness effects
- FDA-approved for narcolepsy; off-label use for cognitive enhancement
- Racetams
- AMPA receptor potentiation
- Enhances synaptic transmission
- No established mitochondrial action
- Low to moderate depending on compound
- Limited human cognitive data; mechanism less clear than claimed
- Creatine
- Phosphocreatine energy buffer
- Supports ATP regeneration during high demand
- Provides substrate for mitochondrial ATP recycling
- None. Dietary supplement
- Strong evidence for short-duration cognitive tasks; less effective for sustained fatigue
- Bottom Line
- MOTS-C is the only intervention on this list that directly increases mitochondrial energy production capacity rather than borrowing against existing reserves or blocking fatigue perception. For sustained cognitive work and genuine fatigue resolution, the metabolic approach wins.